Dechra To Buy Piedmont For $210M, Raises £184M
Veterinary medicine company Dechra Pharmaceuticals on Thursday said it raised £184 million ($220 million) by issuing ordinary shares, coming a day after it agreed to buy U.S.-based pet health company Piedmont...To view the full article, register now.
Already a subscriber? Click here to view full article